These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19916908)

  • 21. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma.
    Zhang H; Ozaki I; Mizuta T; Hamajima H; Yasutake T; Eguchi Y; Ideguchi H; Yamamoto K; Matsuhashi S
    Oncogene; 2006 Oct; 25(45):6101-12. PubMed ID: 16682950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma].
    Gu DH; Zhu YZ; Wang X; Bai ZC; Ping JL; Chen Q; Zhu R
    Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):282-7. PubMed ID: 23985257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
    Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.
    Fan QM; Jing YY; Yu GF; Kou XR; Ye F; Gao L; Li R; Zhao QD; Yang Y; Lu ZH; Wei LX
    Cancer Lett; 2014 Oct; 352(2):160-8. PubMed ID: 24892648
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
    Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB
    World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells.
    Zhong M; Zhong C; Cui W; Wang G; Zheng G; Li L; Zhang J; Ren R; Gao H; Wang T; Li X; Che J; Gohda E
    BMC Cancer; 2019 May; 19(1):439. PubMed ID: 31088527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heme oxygenase-1/carbon monoxide axis suppresses transforming growth factor-β1-induced growth inhibition by increasing ERK1/2-mediated phosphorylation of Smad3 at Thr-179 in human hepatocellular carcinoma cell lines.
    Park SJ; Lee SK; Lim CR; Park HW; Liu F; Kim SJ; Kim BC
    Biochem Biophys Res Commun; 2018 Apr; 498(3):609-615. PubMed ID: 29524413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
    Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transforming growth factor-beta receptors and mannose 6-phosphate/insulin-like growth factor-II receptor expression in human hepatocellular carcinoma.
    Sue SR; Chari RS; Kong FM; Mills JJ; Fine RL; Jirtle RL; Meyers WC
    Ann Surg; 1995 Aug; 222(2):171-8. PubMed ID: 7639583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma.
    Qiu W; David D; Zhou B; Chu PG; Zhang B; Wu M; Xiao J; Han T; Zhu Z; Wang T; Liu X; Lopez R; Frankel P; Jong A; Yen Y
    Am J Pathol; 2003 Jun; 162(6):1961-74. PubMed ID: 12759252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reciprocal activation between MMP-8 and TGF-β1 stimulates EMT and malignant progression of hepatocellular carcinoma.
    Qin G; Luo M; Chen J; Dang Y; Chen G; Li L; Zeng J; Lu Y; Yang J
    Cancer Lett; 2016 Apr; 374(1):85-95. PubMed ID: 26872724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition mechanism of a newly cloned candidate tumor suppressor gene JST during hepatocarcinogenesis and its abnormal expression in human hepatocellular carcinoma from Qidong liver cancer risk area, China.
    Dong-Dong L; Xi-Ran Z
    Hepatogastroenterology; 2004; 51(56):515-25. PubMed ID: 15086194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNMT3a-dermatopontin axis suppresses breast cancer malignancy via inactivating YAP.
    Ye D; Wang Y; Deng X; Zhou X; Liu D; Zhou B; Zheng W; Wang X; Fang L
    Cell Death Dis; 2023 Feb; 14(2):106. PubMed ID: 36774339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
    Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production.
    Ogata H; Chinen T; Yoshida T; Kinjyo I; Takaesu G; Shiraishi H; Iida M; Kobayashi T; Yoshimura A
    Oncogene; 2006 Apr; 25(17):2520-30. PubMed ID: 16474852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EFEMP1 inhibits migration of hepatocellular carcinoma by regulating MMP2 and MMP9 via ERK1/2 activity.
    Dou CY; Cao CJ; Wang Z; Zhang RH; Huang LL; Lian JY; Xie WL; Wang LT
    Oncol Rep; 2016 Jun; 35(6):3489-95. PubMed ID: 27108677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dermatopontin is a novel regulator of the CdCl2-induced decrease in claudin-11 expression.
    Yang Q; Hao J; Chen M; Li G
    Toxicol In Vitro; 2014 Sep; 28(6):1158-64. PubMed ID: 24909373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentially expressed genes associated with hepatitis B virus HBx and MHBs protein function in hepatocellular carcinoma.
    Kim DG
    Methods Mol Biol; 2006; 317():141-55. PubMed ID: 16264227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma.
    Fransvea E; Mazzocca A; Antonaci S; Giannelli G
    Hepatology; 2009 Mar; 49(3):839-50. PubMed ID: 19115199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.